Dr. David L. Cooper was invited to speak at the Cannabis World Congress and Business Exposition at NYC Javits Convention Center on May 31, 2019, after received IRB approval for an Autism Spectrum Disorder Clinical Study.
Dr. Cooper’s presentation focuses on systemic efficacy and safety of CBD and broad-spectrum hemp-based formulations. Dr. Cooper announces IRB approval of first Clinical Study on Broad Spectrum Formulations for patients with ASD.
Cannabis World Congress & Business Expo (CWCBExpo)® 2019 in Javits Center – New York, NY® is the top trade show and conference on the East Coast for the medical and legalized marijuana and hemp industries, covering the most important topics and business objectives needed to succeed in this rapidly changing and growing industry.
May 29 – June 1, 2019
Javits Center – New York, NY | 655 West 34th Street, New York, NY